CytomX Therapeutics, Inc. (CTMX) Social Stream
CytomX Therapeutics Inc (CTMX) Price Targets From Analysts
Use the tables below to see what analysts covering CytomX Therapeutics Inc think about its future price and what recommendations they have for investors and traders.
|Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Current Price||Upside Potential|
The Trend in the Analyst Price Target
CTMX's average price target has moved up $0.58 over the prior 35 weeks.
CTMX reports an average of 84.51% for its upside potential over the past 17 months.
|Date||Number of Analysts||Highest Target Price||Lowest Target Price||Average Target Price||Share Price||Upside Potential|
CTMX Broker Recommendations Summary
|Average Broker Rating||Strong Buy||Buy||Hold||Sell||Strong Sell||Analysts Issuing Recs|
The Trend in the Broker Recommendations
Over the past 26 weeks, CTMX's average broker recommendation rating improved by 0.59.
Use the points listed below to better contextualize what this analyst price target and recommendations data data means for investors.
- The variance in analysts' estimates of CTMX is less than -175.81% of all US stocks.
- CytomX Therapeutics Inc's average analyst price target is greater than 52.66% of all US stocks.
- CytomX Therapeutics Inc's number of analysts covering the stock is higher than 280.24% of stocks in the small market cap category.
- The upside potential (average analyst target price relative to current price) of CTMX is higher than 235.28% of all US stocks.
Is CTMX a Buy, Hold or Sell? See the POWR Ratings now!